CN1068325C - 苯基噁唑烷酮抗菌剂 - Google Patents

苯基噁唑烷酮抗菌剂 Download PDF

Info

Publication number
CN1068325C
CN1068325C CN95195908A CN95195908A CN1068325C CN 1068325 C CN1068325 C CN 1068325C CN 95195908 A CN95195908 A CN 95195908A CN 95195908 A CN95195908 A CN 95195908A CN 1068325 C CN1068325 C CN 1068325C
Authority
CN
China
Prior art keywords
methyl
phenyl
alkyl
fluoro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95195908A
Other languages
English (en)
Chinese (zh)
Other versions
CN1162312A (zh
Inventor
D·K·胡克恩桑
M·R·巴尔巴奇恩
谷口干雄
宗贞清贵
山田弘美
S·J·布里克纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of CN1162312A publication Critical patent/CN1162312A/zh
Application granted granted Critical
Publication of CN1068325C publication Critical patent/CN1068325C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN95195908A 1994-10-26 1995-09-12 苯基噁唑烷酮抗菌剂 Expired - Fee Related CN1068325C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32971794A 1994-10-26 1994-10-26
US08/329,717 1994-10-26

Publications (2)

Publication Number Publication Date
CN1162312A CN1162312A (zh) 1997-10-15
CN1068325C true CN1068325C (zh) 2001-07-11

Family

ID=23286694

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95195908A Expired - Fee Related CN1068325C (zh) 1994-10-26 1995-09-12 苯基噁唑烷酮抗菌剂

Country Status (22)

Country Link
EP (1) EP0788498B1 (ja)
JP (1) JP3933198B2 (ja)
KR (1) KR100383403B1 (ja)
CN (1) CN1068325C (ja)
AT (1) ATE204277T1 (ja)
AU (1) AU694271B2 (ja)
BR (1) BR9509136A (ja)
CA (1) CA2200433C (ja)
CZ (1) CZ291847B6 (ja)
DE (1) DE69522234T2 (ja)
DK (1) DK0788498T3 (ja)
ES (1) ES2162941T3 (ja)
FI (1) FI971774A (ja)
HU (1) HU224044B1 (ja)
NO (1) NO309478B1 (ja)
NZ (1) NZ293741A (ja)
PL (1) PL183512B1 (ja)
PT (1) PT788498E (ja)
RU (1) RU2134692C1 (ja)
SI (1) SI0788498T1 (ja)
SK (1) SK282869B6 (ja)
WO (1) WO1996013502A1 (ja)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11512429A (ja) * 1995-09-15 1999-10-26 ファルマシア・アンド・アップジョン・カンパニー アミノアリールオキサゾリジノン ｎ−オキシド
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
ES2166073T3 (es) * 1996-04-11 2002-04-01 Upjohn Co Procedimiento para preparar oxazolidinonas.
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
KR20010015910A (ko) 1998-01-23 2001-02-26 로렌스 티. 마이젠헬더 옥사졸리디논 조합 라이브러리, 조성물 및 제조 방법
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
ATE222894T1 (de) * 1998-02-13 2002-09-15 Upjohn Co Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
KR20010052615A (ko) 1998-06-05 2001-06-25 다비드 에 질레스 옥사졸리디논 유도체, 이것의 제조 방법 및 이것을함유하는 약학 조성물
EP1159273A1 (en) 1999-03-02 2001-12-05 Boehringer Ingelheim Pharmaceuticals Inc. Compounds useful as reversible inhibitors of cathepsin s
DE19919708A1 (de) * 1999-04-30 2001-03-01 Univ Stuttgart Stufenweise Alkylierung von polymeren Aminen
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
FR2802091A1 (fr) * 1999-12-08 2001-06-15 Oreal Compositions pour la teinture des fibres keratiniques contenant des derives de paraphenylenediamine a groupement azetidinyle
ATE321024T1 (de) 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
YU52403A (sh) 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
US7160912B2 (en) 2000-12-26 2007-01-09 Dr.Reddy's Laboratories Ltd. Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
WO2002064574A2 (en) * 2001-02-07 2002-08-22 Ortho-Mcneil Pharmaceutical, Inc. Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
ES2186550B2 (es) * 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
US6914058B2 (en) * 2002-01-18 2005-07-05 Dr. Reddy's Laboratories, Limited Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
CA2492194A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites
CA2492743A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them
CA2491287A1 (en) 2002-08-12 2004-02-19 Pharmacia & Upjohn Company N-aryl-2-oxazolidinones and their derivatives
BR0316483A (pt) 2002-11-21 2005-10-11 Upjohn Co Derivados de n-(4-(piperazin-1-il)-fenil-2-oxazolidinona-5-carboxami da e compostos relacionados como agentes antibacterianos
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
FR2862969A1 (fr) * 2003-11-28 2005-06-03 Oreal Procede de preparation de derives paraphenylenediamine a groupement pyrrolidinyle, substitue par un radical azote, et composes intermediaires
EP1902048A1 (en) * 2005-07-06 2008-03-26 Pharmacia & Upjohn Company LLC Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
WO2007004049A1 (en) * 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidinones containing azetidine as antibacterial agents
BRPI0812700B1 (pt) 2007-07-24 2020-04-28 Dow Global Technologies Inc método para reduzir ou inibir o aumento na concentração de micróbios anaeróbicos num fluido à base de água e formulação para reduzir ou inibir o aumento na concentração de micróbios anaeróbicos num fluido ou sistema à base de água
DK2175721T3 (da) * 2007-07-24 2017-05-01 Dow Global Technologies Llc Fremgangsmåder og formuleringer til reducering og hæmning af væksten af koncentrationen af mikrober i vandbaserede fluider og systemer, der anvendes med disse
EP2141162A1 (en) 2008-07-01 2010-01-06 Ferrer Internacional, S.A. 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
EP2141161A1 (en) * 2008-07-01 2010-01-06 Ferrer Internacional, S.A. 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
CN101798302B (zh) * 2009-02-06 2014-11-05 上海盟科药业有限公司 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
KR20130102614A (ko) 2010-11-03 2013-09-17 욱크하르트 리미티드 인산 모노-(1-[4-[(s)-5-(아세틸아미노메틸)-2-옥소-옥사졸리딘-3-일]-2,6-디플루오로페닐]-4-메톡시메틸피페리딘-4-일) 에스테르의 제조 방법
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
WO2020234636A1 (en) 2019-05-17 2020-11-26 Cadila Healthcare Limited Novel compounds for the treatment of mammalian infections

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009103A1 (en) * 1991-11-01 1993-05-13 The Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES533097A0 (es) * 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
ATE95176T1 (de) * 1987-10-21 1993-10-15 Du Pont Merck Pharma Aminomethyl-oxo-oxazolidinyl-ethenylbenzenderivate, nuetzlich als antibakterielles mittel.
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
WO1990002744A1 (en) * 1988-09-15 1990-03-22 The Upjohn Company In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009103A1 (en) * 1991-11-01 1993-05-13 The Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents

Also Published As

Publication number Publication date
NO971946D0 (no) 1997-04-25
EP0788498A1 (en) 1997-08-13
WO1996013502A1 (en) 1996-05-09
DE69522234T2 (de) 2002-05-16
JP3933198B2 (ja) 2007-06-20
PL319873A1 (en) 1997-09-01
AU694271B2 (en) 1998-07-16
NO971946L (no) 1997-06-25
CA2200433C (en) 2006-02-07
BR9509136A (pt) 1998-07-21
CN1162312A (zh) 1997-10-15
HUT77602A (hu) 1998-06-29
KR100383403B1 (ko) 2004-05-31
DK0788498T3 (da) 2001-11-05
ATE204277T1 (de) 2001-09-15
SK49497A3 (en) 1998-01-14
PL183512B1 (pl) 2002-06-28
SI0788498T1 (en) 2001-12-31
AU3625495A (en) 1996-05-23
CZ121797A3 (en) 1997-07-16
RU2134692C1 (ru) 1999-08-20
FI971774A0 (fi) 1997-04-25
EP0788498B1 (en) 2001-08-16
NO309478B1 (no) 2001-02-05
HU224044B1 (hu) 2005-05-30
SK282869B6 (sk) 2003-01-09
KR970707123A (ko) 1997-12-01
PT788498E (pt) 2002-02-28
DE69522234D1 (de) 2001-09-20
NZ293741A (en) 1998-06-26
FI971774A (fi) 1997-04-25
ES2162941T3 (es) 2002-01-16
CZ291847B6 (cs) 2003-06-18
JPH10508017A (ja) 1998-08-04
CA2200433A1 (en) 1996-05-09

Similar Documents

Publication Publication Date Title
CN1068325C (zh) 苯基噁唑烷酮抗菌剂
DE60308998T2 (de) N-aryl-2-oxazolidinon-5-carbonsäureamide und deren derivate und deren verwendung als antibakterielle mittel
KR100281775B1 (ko) 치환된 디아진 잔기를 함유하는 옥사졸리디논 항균제
JP2837139B2 (ja) 耐糖能障害・異常の治療用及び予防用医薬剤
CN1273451C (zh) 哌啶mch拮抗剂及其治疗肥胖症的用途
JP2021525219A (ja) がんに対する使用のための、ｅｇｆｒの分解を引き起こす化合物
KR20020067554A (ko) 염증성 질환, 면역성 질환 또는 심혈관계 질환 치료용신규 ｐ2ｘ7 수용체 길항제
US20040147545A1 (en) Derivatives of oxazolidinones as antibacterial agents
CN1250544C (zh) 吡啶并芳基苯基噁唑烷酮抗菌剂和相关组合物及方法
JP2002526410A (ja) タキキニン受容体拮抗剤としてのナフタレンカルボキシアミド
JPH07145057A (ja) 縮合ベンゼンオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
CA2815741A1 (en) Triazole derivatives as ligands for gaba receptors
CN1237056C (zh) 噁唑烷酮类化合物、其制备方法和用途
HUT64759A (en) Method for producing tetrazolyl-(phenoxy-and phenoxy-alkyl-)-pyridinyl-pyridazines
JP2006504726A (ja) 抗菌性１−アリールジヒドロピリドン化合物
EP1773823B1 (fr) Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
JPH0725854A (ja) 縮合ベンゼンオキシ酢酸誘導体
CN1158123A (zh) 用于治疗ii型糖尿病的苯并噁唑吡啶衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee